Reserves (Details) |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Share Capital [Member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | Nominal value of subscribed share capital |
| Share premium [member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | Amount subscribed for share capital in excess of nominal value. |
| Merger Reserve [member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | Represents the difference between the fair value and nominal value of shares issued on the acquisition of subsidiary companies where the Company has elected to take advantage of merger accounting. |
| Reserve of exchange differences on translation [member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | Gains/losses arising on retranslating the net assets of overseas operations into sterling |
| Warrant reserve [member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | Represents the following: · the fair value of warrants denominated in £ at the date of grant. The number and price are fixed at the date of grant. The warrants expired in November 2025. · the fair value of pre-funded warrants granted. The pre-funded warrants do not have an expiry date. · The fair value of Series C warrants denominated in US$ at the date of grant but allow for the warrants to be exercised on an alternative cashless basis effectively allowing the holders to exercise for nil consideration. |
| Retained earnings [member] | |
| IfrsStatementLineItems [Line Items] | |
| Description of nature and purpose of reserves within equity | All other net gains and losses and transactions with owners (e.g., dividends) not recognised elsewhere. |